TWST
Twist Bioscience Corporation
NASDAQ · Healthcare
Twist Bioscience Corporation annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Twist Bioscience Corporation revenue for the quarter ending March 31, 2026 was 110.7 M, a 19.31% increase year-over-year.
- Twist Bioscience Corporation revenue for the twelve months ending March 31, 2026 was 403.3 M, a 27.22% increase year-over-year.
- Twist Bioscience Corporation annual revenue for 2025 was 376.6 M, a 20.32% increase from 2024.
- Twist Bioscience Corporation annual revenue for 2024 was 313.0 M, a 27.69% increase from 2023.
- Twist Bioscience Corporation annual revenue for 2023 was 245.1 M, a 20.41% increase from 2022.
- Twist Bioscience Corporation annual revenue for 2022 was 203.6 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %